Connect with us

Health

Tommy John surgery continues to save baseball careers 50 years after its debut: 'Revolutionary'

Published

on

Tommy John surgery continues to save baseball careers 50 years after its debut: 'Revolutionary'

It’s been nearly 50 years since one of the biggest advancements in sports medicine: Tommy John surgery.

On Sept. 25, 1974, Dr. Frank Jobe first performed the operation on Tommy John, a professional baseball pitcher who played on Major League Baseball (MLB) teams between 1963 and 1989.

During the surgery, Jobe reconstructed a torn ulnar collateral ligament (UCL) in John’s left arm. 

ON THIS DAY IN HISTORY, MARCH 7, 1857, BASEBALL ADOPTS NINE PLAYERS, NINE INNINGS AS STANDARD OF COMPETITION

It was a pioneering achievement for Jobe and a lifeline for John, who went from a career-ending injury to 14 more years in the majors — and an eponymous connection to sports medicine that would live on long past his playing days.

Advertisement

Since then, Tommy John surgery — more formally known as ulnar collateral ligament (UCL) reconstruction, according to Johns Hopkins Medicine — has been performed on many other baseball players. 

New York Yankees pitcher Tommy John delivering a pitch versus the Kansas City Royals during a game at Yankee Stadium on July 9, 1988, in New York.  (Getty Images)

Those players include David Wells (1985), John Smoltz (2000), Stephen Strasburg (2010), Rich Hill (2011), Shohei Ohtani (2018), Justin Verlander (2020) and Bryce Harper (2022), to name a few, according to MLB. 

“I wouldn’t still be standing here if it weren’t for a surgery like this,” Chicago White Sox pitcher Michael Kopech said, according to the Associated Press. “It’s doubled the length of my career.”

ON THIS DAY IN HISTORY, JANUARY 31, 1919, JACKIE ROBINSON IS BORN IN GEORGIA — BASEBALL PIONEER, WWII VETERAN

Advertisement

John Gallucci, a New Jersey-based physical therapist specializing in sports injuries, noted that Tommy John surgery has prolonged and saved many careers.

“Before this surgery, a torn UCL was considered a career-ending injury,” he told Fox News Digital. 

“This surgery was a major advancement in treatment and was revolutionary for athletes and those who suffer from elbow injuries.”

Dr. Frank Jobe, orthopedic surgeon and Los Angeles Dodgers team physician, pioneered elbow ligament replacement and shoulder surgery for baseball players, a procedure commonly known today as Tommy John surgery. Jobe is pictured here in 1997. (Getty Images)

Alongside arthroscopic surgery and ACL reconstruction, Tommy John surgery is one of the biggest advancements in sports medicine in the last 50 years, according to Dr. Tim Kremchek, a longtime physician for the Cincinnati Reds.

Advertisement

“It [has] just prolonged and saved so many careers,” he said to the AP. 

“Not just in baseball, but now for some other sports that we’re doing it for — so many other athletes, especially overhead athletes. But in terms of baseball, I think it’s allowed us to see some of the greatest players in the world continue to play for a long period of time.”

“It’s allowed us to see some of the greatest players in the world continue to play for a long period of time.”

In the debut operation at Rancho Los Amigos, a Southern California hospital, Jobe removed the palmaris longus tendon from John’s right arm, drilled four holes in his left elbow — and then used the tendon to replace the torn ligament.

“It wasn’t a new idea,” Jobe said in July 2013, about seven months before he died. 

Advertisement

“It was just new for the elbow.”

In the first procedure, Jobe removed the palmaris longus tendon from John’s right arm, drilled four holes in his left elbow, and then used the tendon to replace the torn ligament (not pictured). (iStock)

The procedure itself hasn’t changed much since Jobe pioneered it, though doctors have made a few improvements.

“It has remained primarily the same, but advancements have been made,” said Gallucci. 

“These advancements have made the surgery even more effective in tandem with work from physical therapists and certified athletic trainers during the recovery process.”

Advertisement

BASEBALL QUIZ! HOW WELL DO YOU KNOW THE POPULAR AMERICAN SPORT?

“Due to the advancements made and the rehabilitation process improvements, the standard recovery period has been cut nearly in half from what it was 50 years ago,” he added.

The effects of Tommy John surgery have been seen in players’ performance on the field.

Verlander won the AL Cy Young Award in 2022, two years after he had Tommy John surgery. 

Tommy John of the New York Yankees is pictured prior to the start of a Major League Baseball game circa 1987 at Yankee Stadium in the Bronx, New York. (Getty Images)

Advertisement

Harper, who had the procedure in Nov. 2022, returned to Philadelphia’s lineup in May.

Dodgers pitcher Tyler Glasnow, who had Tommy John in 2021, struck out 162 batters in a career-high 120 innings last year. 

Within months of receiving his second major elbow operation, Ohtani landed a record-breaking $700 million contract from the Los Angeles Dodgers.

“There’s no question that Tommy John is the most valuable reconstructive procedure there is.”

“If you put it in dollars and cents, I think there’s no question that Tommy John is the most valuable reconstructive procedure there is,” Dr. Neal ElAttrache, the head team physician for the Dodgers and the NFL’s Los Angeles Rams, told the AP.

Advertisement

Despite its high success rate, the main challenge associated with the surgery has been the extended recovery and rehabilitation process.

For about 10 days after the surgery, the patient must wear a cast at a 90-degree angle. 

“It wasn’t a new idea,” Jobe said in July 2013, about seven months before he died. “It was just new for the elbow.” (Getty Images)

It then takes months for the player to regain a full range of motion, and usually at least a year before returning to the field.

“Although this surgery was revolutionary, the road to recovery is no easy process — and that is where physical therapy comes into play,” said Gallucci, who has seen patients throughout the years in rehab from Tommy John surgery. 

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“It requires commitment from the patient, as it is no easy feat,” he said. 

“Although it takes a few months of rehab and slowly increasing strengthening exercises, I have seen patients make a full recovery and be able to play again.”

Dodgers pitcher Tony Gonsolin, who had surgery on Sept. 1, recalled his first day of throwing after the operation.

Tommy John, the 4-time All Star pitcher who won 288 games, is pictured at right with Tommy John III, a chiropractor in sports medicine. (Getty Images)

Advertisement

“It was like 30 throws, nice and easy, and just felt super foreign, like I’d never thrown before,” he said, as the AP reported. “Took some video on it, and they did not look pretty at all. Then I threw a couple [of] days later and it felt much better.”

Approaching the 50th anniversary of the surgery, Gonsolin said he is grateful for the medical advancement that started with Tommy John in 1974.

“I think the evolution of the surgery and just the sheer medical breakthrough from it allows [it] to extend people’s careers,” he said.

“It gives everybody a second opportunity.”

Advertisement

The Associated Press contributed to this report.

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

Goodbye, Late-Night Cravings! How To Curb Hunger and Make Weight Loss Easier

Published

on

Goodbye, Late-Night Cravings! How To Curb Hunger and Make Weight Loss Easier


Advertisement





How To Curb Late-Night Cravings and Make Weight Loss Easier | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Lurking dementia risk exposed by breakthrough test 25 years before symptoms

Published

on

Lurking dementia risk exposed by breakthrough test 25 years before symptoms

NEWYou can now listen to Fox News articles!

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge.

Advertisement

That’s according to new research from the University of California San Diego, which found that a specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk.

The researchers analyzed blood samples from 2,766 participants in the Women’s Health Initiative Memory Study in the late 1990s, according to the study’s press release. 

KEY FITNESS MEASURE IS STRONG PREDICTOR OF LONGEVITY AFTER CERTAIN AGE, STUDY FINDS

The women ranged from 65 to 79 years of age and showed no signs of cognitive decline at the start of the study.

After tracking the participants for up to 25 years, the researchers concluded that the biomarker phosphorylated tau 217 (p-tau217) was “strongly associated” with future mild cognitive impairment and dementia. 

Advertisement

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. (iStock)

Women who had higher levels of p-tau217 at the beginning of the study were “much more likely” to develop the disease. The findings were published today in JAMA Network Open.

“The key takeaway is that our study suggests it may be possible to detect risk of dementia two decades in advance using a simple blood test in older women,” first author Aladdin H. Shadyab, a UC San Diego associate professor of public health and medicine, told Fox News Digital. 

“These biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia.”

“Our findings show that the blood biomarker p-tau217 could help identify individuals at higher risk for dementia long before symptoms begin,” he added.

Advertisement

This long lead time could open the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life, according to Shadyab.

A specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk. (iStock)

“As the research advances, these biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia,” he said.

This risk relationship wasn’t the same across the board, however. Women over 70 with higher p-tau217 levels had “poorer cognitive outcomes” compared to those under 70, as did those with the APOE ε4 gene, which is a known risk factor for Alzheimer’s disease.

Advertisement

The study also found that p-tau217 was a stronger predictor of dementia in women who were randomly assigned to receive estrogen and progestin hormone therapy compared to those who received a placebo.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” said senior author Linda K. McEvoy, senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health, in the release. 

“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” a researcher said. (iStock)

“This is important for accelerating research into the factors that affect the risk of dementia and for evaluating strategies that may reduce risk.”

Advertisement

Blood tests for Alzheimer’s disease are still being studied and are not recommended for routine screening in people without symptoms, Shadyab noted. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

More research is needed before this approach can be considered for clinical use prior to cognitive symptoms. 

Future studies should investigate how other factors — like genetics, hormone therapy and age-related medical conditions — might interact with plasma p-tau217, the researchers added.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

“The study examined only older women, so the findings may not necessarily apply to men or younger populations,” Shadyab noted. “We also examined overall dementia outcomes rather than specific subtypes such as Alzheimer’s disease.”

Continue Reading

Health

Key fitness measure is strong predictor of longevity after certain age, study finds

Published

on

Key fitness measure is strong predictor of longevity after certain age, study finds

NEWYou can now listen to Fox News articles!

For women over 60, muscle strength plays a critical role in longevity, a new study confirms.

Researchers at the University at Buffalo, New York, followed more than 5,000 women between the ages of 63 and 99, finding that those with greater muscle strength had a significantly lower risk of death over an eight-year period.

The findings were published in JAMA Network Open.

EXERCISE AFFECTS THE HEART IN A HIDDEN, POWERFUL WAY BY REWIRING NERVES, STUDY FINDS

Advertisement

Muscle function was measured using grip strength and how quickly participants could complete five unassisted sit-to-stand chair raises. 

These are two tests commonly used in clinical settings to evaluate muscle function in older adults, the researchers noted.

A recent study shows that stronger muscle strength in women over 60 is linked to a lower risk of death over eight years. (iStock)

“In a community cohort of ambulatory older women, muscular strength was associated with significantly lower mortality rates, even when we accounted for usual physical activity and sedentary time measured using a wearable monitor, gait speed and blood C-reactive protein levels,” study lead author Michael LaMonte, research professor of epidemiology and environmental health at the University at Buffalo, told Fox News Digital.

“Movement is the key — just move more and sit less.”

Advertisement

Many earlier studies did not include those objective measurements, making it difficult to determine whether muscle strength itself was linked to longevity, according to LaMonte. “Our study was able to better isolate the association between strength and death in later life,” he added.

Even for women who don’t get the recommended amount of aerobic physical activity, which is at least 150 minutes per week, muscle strength remained important for longevity, the researchers found.

Women with greater muscle strength were more likely to live longer, even if they did not meet the recommended amount of aerobic exercise. (iStock)

“The findings of lower mortality in those who had higher strength but were not meeting current national guidelines on aerobic activity were somewhat intriguing,” LaMonte said.

Advertisement

CLICK HERE FOR MORE LIFESTYLE STORIES

Federal guidelines recommend strengthening activities one to two days per week, targeting major muscle groups.

Resistance training does not have to require a gym membership, LaMonte noted. These exercises can be performed using free weights, resistance bands, bodyweight movements or even household items, such as soup cans.

Experts recommend working major muscle groups one or two days a week using weights, bands or bodyweight exercises. (iStock)

“Movement is the key — just move more and sit less,” he said. “When we can no longer get out of the chair and move around, we are in trouble.”

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

LaMonte acknowledged several limitations of the study. The researchers assessed muscle strength in older age but did not explore how earlier levels in adulthood might influence long-term health outcomes.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“We were not able to understand how strength and mortality relate in younger ages,” he said, noting that future research should explore whether building strength earlier could have an even greater impact on longevity.

Advertisement
Continue Reading

Trending